BioSpace News Archive

Electromed announced that it will issue its financial results press release for the fiscal 2018 second quarter ended December 31, 2017 on Tuesday, February 13, 2018 after the close of the stock market.

The innovative NVMF lens design allows it to be used for both myopic progression control and presbyopia.

The following is a statement from Wouter Latour, M.D., Chief Executive Officer of Vaxart, who will lead the combined company following completion of the transaction:

Vaxart announced today that its investigational H1 influenza oral tablet vaccine demonstrated a statistically significant reduction in the rate of influenza infection compared with placebo, and compared favorably with the market-leading injectable quadrivalent influenza vaccine (QIV) in a Phase 2 challenge trial.

The Association of Clinical Research Organizations (ACRO) is pleased to announce that its written comments to regulatory public consultations in both the U.S. and EU are now available on its website.

Seres Therapeutics announced the appointment of Eric D. Shaff to the additional role of Chief Operating Officer. Mr. Shaff has been Executive Vice President and Chief Financial Officer since joining the Company in November 2014, and he will continue to retain both positions.

Following the entry of Nanjing Ying Peng, Mr. Ping Xu was appointed as a director of the Board of Directors of the Company.

DOF Inc has launched the ‘SHARP 2 PLUS’, an upgraded version of its five-axis milling machine ‘SHARP2-5X’.

With its two-year ADCF partnership, Henry Schein will donate health care product kits valued at $5,000 each, containing gloves, gauze, gowns, and masks.

CENTOGENE announced it has surpassed more than one billion identified alleles in their global patient cohorts within its database of more than 200,000 patient samples.